IRIS
CHIEFFO, ALAIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.799
NA - Nord America 3.076
EU - Europa 2.082
SA - Sud America 1.474
AF - Africa 83
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 12.524
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.911
SG - Singapore 2.819
CN - Cina 1.356
BR - Brasile 1.247
HK - Hong Kong 874
SE - Svezia 412
IT - Italia 395
VN - Vietnam 381
RU - Federazione Russa 315
RO - Romania 280
DE - Germania 177
AR - Argentina 104
GB - Regno Unito 99
IN - India 72
CA - Canada 68
AT - Austria 67
FI - Finlandia 65
MX - Messico 61
NL - Olanda 60
BD - Bangladesh 53
EC - Ecuador 44
PL - Polonia 42
TR - Turchia 41
IQ - Iraq 38
IE - Irlanda 37
ES - Italia 33
ZA - Sudafrica 31
JP - Giappone 30
ID - Indonesia 29
FR - Francia 27
PY - Paraguay 25
CO - Colombia 22
PK - Pakistan 18
UA - Ucraina 14
CH - Svizzera 13
MA - Marocco 13
LT - Lituania 12
IR - Iran 11
UZ - Uzbekistan 11
CL - Cile 10
TN - Tunisia 10
NP - Nepal 9
JM - Giamaica 8
VE - Venezuela 8
PE - Perù 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
HN - Honduras 6
JO - Giordania 6
AZ - Azerbaigian 5
CR - Costa Rica 5
EG - Egitto 5
KE - Kenya 5
DO - Repubblica Dominicana 4
GR - Grecia 4
GT - Guatemala 4
RS - Serbia 4
UY - Uruguay 4
AL - Albania 3
AU - Australia 3
BE - Belgio 3
BO - Bolivia 3
ET - Etiopia 3
GE - Georgia 3
IL - Israele 3
KR - Corea 3
KW - Kuwait 3
OM - Oman 3
SC - Seychelles 3
TH - Thailandia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
MK - Macedonia 2
PH - Filippine 2
SI - Slovenia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TV - Tuvalu 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
KY - Cayman, isole 1
LB - Libano 1
Totale 12.511
Salva come PNG Salva come JPEG
Città #
Singapore 1.251
Dallas 1.114
Hong Kong 864
Hefei 374
Shanghai 340
Ashburn 284
Ho Chi Minh City 157
Lawrence 149
Princeton 149
Beijing 121
New York 115
Milan 114
São Paulo 113
Moscow 103
Los Angeles 72
Hanoi 67
Nuremberg 51
Munich 43
Helsinki 39
Santa Clara 36
Dublin 34
Warsaw 31
Amsterdam 30
Belo Horizonte 30
Boardman 30
Brooklyn 29
Montreal 29
Brasília 28
Denver 28
Tokyo 28
Vienna 28
Rio de Janeiro 26
Rome 23
Chennai 22
London 22
Stockholm 22
Guangzhou 21
Mexico City 20
Orem 20
Atlanta 19
Guayaquil 19
Johannesburg 19
Seattle 19
Ankara 18
Baghdad 18
Haiphong 18
Manchester 17
Phoenix 17
Chicago 16
Poplar 16
Salvador 16
Tianjin 16
Xi'an 16
Guarulhos 15
Boston 14
Buffalo 14
Dhaka 14
Goiânia 13
Manaus 13
Porto Alegre 13
San Francisco 13
Lappeenranta 12
Turku 12
Asunción 11
Charlotte 11
Shenzhen 11
Toronto 11
Assago 10
Bauru 10
Biên Hòa 10
Campinas 10
Da Nang 10
Quito 10
Recife 10
Sorocaba 10
Thái Bình 10
Council Bluffs 9
Falkenstein 9
Hangzhou 9
Jakarta 9
Mumbai 9
São Gonçalo 9
Bogotá 8
Caxias do Sul 8
Curitiba 8
Fortaleza 8
Houston 8
Ittigen 8
Miami 8
New Delhi 8
Santa Maria 8
Santo André 8
Stockton 8
Tashkent 8
Viamão 8
Alcamo 7
Betim 7
Camaçari 7
Can Tho 7
Cesano Boscone 7
Totale 6.761
Salva come PNG Salva come JPEG
Nome #
European Bifurcation Club white paper on stenting techniques for patients with bifurcated coronary artery lesions 345
Prognostic impact of mitral regurgitation changes after TAVI 195
Aims and Rationale of a National Registry Integrating Clinical, Echocardiographic, and Multi-Omics Profiling to Promote Precision Medicine in Peripartum Cardiomyopathy 148
A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation 126
5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience 117
A Comparison of the Femoral and Radial Crossover Techniques for Vascular Access Management in Transcatheter Aortic Valve Implantation: The Milan Experience 117
A comparison Of The Femoral And Radial Crossover Techniques For Vascular Access Management In Transcatheter Aortic Valve Implantation: The Milan Experience 111
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 105
A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience 90
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 90
Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience 85
Coronary Protection to Prevent Coronary Obstruction During TAVR 82
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 81
A challenging case of transcatheter aortic prosthesis dysfunction: Endocarditis or thrombosis? 81
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 79
A systematic transoesophageal echocardiography study of suture-mediated percutaneous patent foramen ovale closure 78
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC) 77
Observational Multicenter Registry of Patients Treated with IMPella Mechanical Circulatory Support Device in ITaly: The IMP-IT Registry 75
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease 73
A complex valve anatomy for mitraclip: Forme fruste of Barlow’s disease with cleft 70
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 70
"Procedural trauma risks longitudinal shortening of the Promus Element™ stent platform" 66
A novel supra-annular plane that predicts TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane 66
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting 65
Valve-in-valve transcatheter aortic valve implantation: The issues behind crossing a bioprosthesis 64
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 60
Percutaneous coronary intervention for unprotected left main distal bifurcation lesions in elderly people 60
Active Protection of High-Risk Small Side Branches in Bifurcation Interventions Is Preventing Occlusion Always Clinically Relevant? 60
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices 60
Impact of Ascending Aorta Dilation on Mid-Term Outcome After Transcatheter Aortic Valve Implantation 59
Impact on Outcome of Different Mechanisms, Baseline Degree and Changes of Mitral Regurgitation in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement 58
Repeated Transcatheter Valve Interventions After Surgical Mitral Valve Replacement: A 20-Year Journey Avoiding Surgical Redo 58
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 58
A New Tool to Manage Side-Branch Occlusion After Covered-Stent Implantation for Vascular Complications The Neocarina Reconstruction Technique 57
A High Dose of Adenosine to Induce Transient Asystole for Valvuloplasty in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): Is it a Valid Alternative to Rapid Pacing? A Prospective Pilot Study 56
Impact of Left Main Calcium With Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Left Main Narrowings (from the Milan and New-Tokyo Registry) 54
A novel approach to chronic total occlusions: the crosser system 54
Sex-Specific Considerations in Degenerative Aortic Stenosis for Female-Tailored Transfemoral Aortic Valve Implantation Management 53
Sex and Transcatheter Aortic Valve Implantation: Impact of Female Sex on Clinical Outcomes 53
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents 53
Real-Time Intravascular Ultrasound Guidance for Ultra-Low Contrast Complex Bifurcation Percutaneous Coronary Intervention 50
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 50
Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry 49
Polymer-Free Biolimus-Eluting Stents or Polymer-Based Zotarolimus-Eluting Stents for Coronary Bifurcation Lesions 49
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 49
Coronary Artery Aneurysm Thrombosis Causing Acute Myocardial Infarction in an Adolescent With Neurofibromatosis Type 1 48
Supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease: the LIRA method 47
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 47
Challenges and Opportunities for Women in Vascular Surgery: Summary from an International Roundtable Discussion 46
Impact of Post-Percutaneous Coronary Intervention Fractional Flow Reserve Measurement on Procedural Management and Clinical Outcomes: The REPEAT-FFR Study 45
Vascular Access Management for Transcatheter Aortic Valve Implantation - Procedural Results from the Crossover Balloon Technique 45
Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve 45
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 45
Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis SCOPE 2 Randomized Clinical Trial 44
Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations An Analysis From the RAIN-CARDIOGROUP VII Study 44
Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: The INTERSECT registry 44
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 44
Ultrasound-Assisted, Catheter-Directed Thrombolysis for Acute Intermediate/High-Risk Pulmonary Embolism: Design of the Multicenter USAT IH-PE Registry and Preliminary Results 44
Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week 43
Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions 43
Impact of Mean Platelet Volume on Combined Safety Endpoint and Vascular and Bleeding Complications following Percutaneous Transfemoral Transcatheter Aortic Valve Implantation 43
Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score-matched case-control study 43
Interatrial Septal Tear After Patent Foramen Ovale Closure With the NobleStitch Device 43
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 43
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 43
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 42
Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry 42
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting 42
Correction: Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry (vol 14, pg 198, 2021) 41
Can a mechanical circulatory support comprehensive approach to cardiogenic shock at referral centers reduce 30-day mortality? 41
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries 41
Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside 41
ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes 41
Gender-Related Differences in Clinical Presentation and Angiographic Findings in Patients with Ischemia and No Obstructive Coronary Artery Disease (INOCA): A Single-Center Observational Registry 41
The feasibility of double stent strategy in left main true bifurcation with small and large angle change between diastole and systole: The Milan and New-Tokyo (MITO) registry 40
Sex Differences in Use of Intracoronary Imaging in Patients Undergoing Percutaneous Coronary Intervention 40
Transcatheter aortic bioprosthesis durability: A single center experience 40
Dual antiplatelet therapy after drug-eluting stents. How long to treat? 40
Rate of progression of ascending aorta dilatation in patients with bicuspid and tricuspid aortic valve 40
Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 H) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement 40
Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes 39
Discrepancies in vessel sizing between angiography and intravascular ultrasound varies according to the vessel evaluated 39
Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry) 39
Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement 38
Impact of Chronic Kidney Disease in Patients With Diabetes Mellitus after Percutaneous Coronary Intervention for Left Main Distal Bifurcation (From the Milan and New-Tokyo (MITO) Registry) 38
Coronary Vasomotor Disorders: One Size Does Not Fit All 38
Mid-term clinical outcomes after bailout drug-eluting stenting for suboptimal drug-coated balloon results: Insights from a Milan registry 38
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 38
Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment 38
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 38
Tricento Transcatheter Heart Valve for Severe Tricuspid Regurgitation: Procedural Planning and Technical Aspects 38
Comparison of Incidence and Predictors of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Using the CoreValve Versus the Edwards Valve 38
VASCULAR COMPLICATIONS FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION WITH BOTH EDWARDS SAPIEN AND MEDTRONIC COREVALVE(R) BIOPROSTHESIS USING TRANSFEMORAL APPROACH SUPPORTED BY THE CROSS-OVER TECHNIQUE 38
The development of a Hub & Spoke network for transcatheter aortic valve replacement procedures: the operational model of the Interventional Cardiology Unit at the IRCCS San Raffaele Hospital (OSR Hub-Spoke) 38
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2 37
Percutaneous treatment of acute pulmonary embolism: state of the art 37
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 37
Emergency department cardiovascular disease encounters and associated mortality in patients with cancer: A study of 20.6 million records from the USA 37
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 37
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 37
Totale 5.914
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 16 1 0 1 0 0 0
2021/202279 0 0 0 40 4 2 6 7 5 0 4 11
2022/2023964 328 170 45 5 2 83 35 46 18 10 14 208
2023/2024670 124 41 84 38 53 86 6 49 16 15 47 111
2024/20254.728 507 73 73 83 113 381 964 299 754 699 399 383
2025/20266.506 1.054 1.259 1.306 1.814 1.011 62 0 0 0 0 0 0
Totale 13.034